Metaplastic carcinoma of the breast: case series of a single institute and review of the literature

A Papatheodoridi, E Papamattheou, S Marinopoulos… - Medical …, 2023 - mdpi.com
Metaplastic carcinoma of the breast (MpBC) is a very rare and aggressive type of breast
cancer. Data focusing on MpBC are limited. The aim of this study was to describe the …

[PDF][PDF] Metaplastic breast carcinoma: analysis of clinical and pathologic features, a five-year study

D Chaudhary, K Balhara, S Mandal… - Journal of Cancer …, 2023 - journals.lww.com
Background: Metaplastic carcinoma breast (MCB) is a rare tumor comprising of both
glandular and non-glandular patterns with epithelial and or mesenchymal components. Due …

Clinicopathological characteristics of metaplastic breast cancer–analysis of the basic immunohistochemical profile and comparison with other invasive breast cancer …

MP Budzik, J Patera, M Sobol, AI Czerw, A Deptała… - The Breast, 2019 - Elsevier
Abstract Introduction Metaplastic breast cancer (MpBC) is a rare but aggressive type of
breast cancer accounting for 0.25–1% of all diagnosed invasive breast cancers …

Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study

E Morgan, A Suresh, A Ganju, DG Stover… - World journal of surgical …, 2020 - Springer
Background Metaplastic breast cancer remains poorly characterized given its rarity and
heterogeneity. The majority of metaplastic breast cancers demonstrate a phenotype of triple …

Clinicopathologic characteristics and outcome descriptors of metaplastic breast carcinoma

E Abada, F Daaboul, K Ebare… - … of Pathology & …, 2022 - meridian.allenpress.com
Context.—Metaplastic breast carcinoma is an aggressive form of breast cancer that accounts
for 0.5% to 3% of all breast cancers. Objective.—To study the clinicopathologic …

[HTML][HTML] Clinicopathologic features of metaplastic breast carcinoma: experience from a tertiary cancer center of North India

VV Damera, Z Chowdhury, M Tripathi, R Singh… - Cureus, 2022 - ncbi.nlm.nih.gov
Materials and methods In this study, the authors retrospectively analyzed the prospectively
maintained data of MBC patients treated at a tertiary cancer care center in North India …

Metaplastic breast carcinoma with osseous differentiation: A report of a rare case and literature review

C Huang, H Tian, J Xu, F Tong, D Fang - Open Life Sciences, 2023 - degruyter.com
Metaplastic matrix-producing breast carcinoma is a type of metaplastic breast carcinoma
(MBC), which is a rare malignancy, accounting for 0.2–1% of breast carcinomas. A 52-year …

[HTML][HTML] Metaplastic breast carcinoma: a retrospective study of 26 cases

X Zhou, X Wu, L Wang, J Guo, Q Wu… - … Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
Metaplastic breast carcinoma is a rare invasive breast cancer. Metaplastic breast carcinoma
is mainly characterized by an epithelial or mesenchymal cell population mixed with …

Metaplastic breast cancer: Experience with ifosfamide based chemotherapy

N Gupta, S Dogra, K Dimri, AK Pandey, JS Jose… - Current Problems in …, 2024 - Elsevier
Background Metaplastic breast cancer (MPBC) is a rare variant of breast cancer and most
treatment protocols are based on the guidelines for triple negative breast cancer. However …

[HTML][HTML] Metaplastic breast carcinoma with invasive and high-grade ductal carcinoma in situ; a rare case with review of literature

ZD Hammood, AM Salih, RQ Salih… - International Journal of …, 2022 - Elsevier
Introduction Metaplastic breast carcinoma (MBC) represents a rare disease entity of a
heterogeneous group of primary breast malignancies with an incidence of 0.25%–1% of all …